Table IV.
MO17974 trial
|
ML18511 trial
|
||||
---|---|---|---|---|---|
Erlotinib dose (mg)
| |||||
Response | 100 | 125 | 150 | 100 | 150a |
PR | 2 | 1 | - | 3 | 1 |
SD | 1 | 2 | 5 | 1 | 1 |
PD | - | - | 1 | 2 | - |
One patient in this cohort was not evaluable for response.
PR, partial response; SD, stable disease; PD, progressive disease.